Target Price | $6.12 |
Price | $4.04 |
Potential |
51.49%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Repro-Med Systems, Inc. 2026 .
The average Repro-Med Systems, Inc. target price is $6.12.
This is
51.49%
register free of charge
$7.35
81.93%
register free of charge
$3.54
12.50%
register free of charge
|
|
A rating was issued by 11 analysts: 9 Analysts recommend Repro-Med Systems, Inc. to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Repro-Med Systems, Inc. stock has an average upside potential 2026 of
51.49%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 33.65 | 39.76 |
17.99% | 18.15% | |
EBITDA Margin | -16.52% | -2.69% |
49.87% | 83.72% | |
Net Margin | -18.04% | -9.17% |
62.56% | 49.16% |
7 Analysts have issued a sales forecast Repro-Med Systems, Inc. 2025 . The average Repro-Med Systems, Inc. sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Repro-Med Systems, Inc. EBITDA forecast 2025. The average Repro-Med Systems, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Repro-Med Systems, Inc. Analysts have issued a net profit forecast 2025. The average Repro-Med Systems, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.13 | -0.08 |
56.67% | 38.46% | |
P/E | negative | |
EV/Sales | 4.40 |
7 Analysts have issued a Repro-Med Systems, Inc. forecast for earnings per share. The average Repro-Med Systems, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Repro-Med Systems, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Piper Sandler |
Locked
➜
Locked
|
Locked | May 08 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 14 2025 |
Craig-Hallum |
Locked
➜
Locked
|
Locked | Jan 17 2025 |
Lake Street |
Locked
➜
Locked
|
Locked | Jan 14 2025 |
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Nov 14 2024 |
Craig-Hallum |
Locked
➜
Locked
|
Locked | Nov 14 2024 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Nov 14 2024 |
Analyst Rating | Date |
---|---|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 08 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 14 2025 |
Locked
Craig-Hallum:
Locked
➜
Locked
|
Jan 17 2025 |
Locked
Lake Street:
Locked
➜
Locked
|
Jan 14 2025 |
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Nov 14 2024 |
Locked
Craig-Hallum:
Locked
➜
Locked
|
Nov 14 2024 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Nov 14 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.